1 completed, 1 terminated, 1 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Cryptogenic Organizing Pneumonia: new trials by email Literature Review of Cryptogenic Organizing Pneumonia trials Research Report on Cryptogenic Organizing Pneumonia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Screening Microorganism of Cryptogenic Mechanical Pneumonia Through Next Generation Sequencing to Lung Tissue Fluid Next-generation sequencing - Cryptogenic Organizing Pneumonia, Idiopathic Interstitial Pneumonias | Unknown | Shanghai Pulmonary Hospital, Shanghai, China | 100 | 2020-08-07 | 2020-09-01 | |
| Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT Bardoxolone methyl, Placebo - Pulmonary Arterial Hypertension, Pulmonary Hypertension | Phase 2 | Completed | Biogen | 166 | 2014-05-31 | 2025-06-10 |
| Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant Prednisone, Azithromycin, Montelukast - Respiratory Tract Infections, Bronchiolitis Obliterans | Phase 2 | Terminated | Maisonneuve-Rosemont Hospital | 12 | 2011-09-01 | 2021-10-20 |
Idiopathic Interstitial Pneumonias (2) · Lung Diseases, Interstitial (2) · Bronchiolitis Obliterans (1) · Hamman-Rich Syndrome (1) · Hypertension, Pulmonary (1) · Idiopathic Pulmonary Fibrosis (1) · Interstitial Pneumonitis, Desquamative, Familial (1) · Pulmonary Arterial Hypertension (1) · Pulmonary Disease, Chronic Obstructive (1) · Respiratory Tract Infections (1) · Sarcoidosis (1)
Bronchial Diseases (3) · Bronchiolitis (3) · Bronchitis (3) · Lung Diseases (3) · Lung Diseases, Obstructive (3) · Organizing Pneumonia (3) · Pulmonary Fibrosis (3) · Respiratory Tract Diseases (3) · Bronchiolitis Obliterans (2) · Idiopathic Pulmonary Fibrosis (2) · Cardiovascular Diseases (1) · Chronic Disease (1) · Disease Attributes (1) · Hemic and Lymphatic Diseases (1) · Hypersensitivity (1)
Azithromycin (1) · Budesonide (1) · Budesonide, Formoterol Fumarate Drug Combination (1) · Formoterol Fumarate (1) · ORF 50 transactivator (1) · Prednisone (1) · Steroids (1) · bardoxolone methyl (1) · montelukast (1)
Biogen (1) · Maisonneuve-Rosemont Hospital (1) · Shanghai Pulmonary Hospital, Shanghai, China (1)
Canada (1) · China (1) · Germany (1) · United States (1)
Elizabeth F Krakow, MD,CM, FRCPC (1) · Sandra Cohen, MD, FRCPC (1)